Hims & Hers Health Options Spot-On: On January 17th, 102.64K Contracts Were Traded, With 520.85K Open Interest
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
Hims & Hers Health Down 3% After BoA Says Q4 Revenue Could Be a Miss
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $18
Cautious Outlook on Hims & Hers Health Amid Regulatory Risks and Revenue Concerns
Express News | U.S. FDA Chief Califf Says Current Regulations Not Enough To Protect Americans From Risks Of Compounded GLP-1 Drugs
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
